APA (7th ed.) Citation

L, R., TW, K., AJ, V., H, G., NF, A., RS, P., . . . N, A. (2021). Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry. British journal of haematology, 193(1), 119. https://doi.org/10.1111/bjh.16806

Chicago Style (17th ed.) Citation

L, Redder, et al. "Validation of the UK Myeloma Research Alliance Risk Profile, a New Clinical Prediction Model for Outcome in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Autologous Stem Cell Transplantation; a Population-based Study from the Danish National Multiple Myeloma Registry." British Journal of Haematology 193, no. 1 (2021): 119. https://doi.org/10.1111/bjh.16806.

MLA (9th ed.) Citation

L, Redder, et al. "Validation of the UK Myeloma Research Alliance Risk Profile, a New Clinical Prediction Model for Outcome in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Autologous Stem Cell Transplantation; a Population-based Study from the Danish National Multiple Myeloma Registry." British Journal of Haematology, vol. 193, no. 1, 2021, p. 119, https://doi.org/10.1111/bjh.16806.